Innoviva, Inc.INVANASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
71.24%
↓ 82% below average
Average (39q)
388.75%
Historical baseline
Range
High:14495.00%
Low:-100.00%
CAGR
+2.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 71.24% |
| Q2 2025 | 81.60% |
| Q1 2025 | 19.95% |
| Q4 2024 | 3.21% |
| Q3 2024 | 38.71% |
| Q2 2024 | -33.99% |
| Q1 2024 | 64.60% |
| Q4 2023 | -40.94% |
| Q3 2023 | -73.39% |
| Q2 2023 | 19.07% |
| Q1 2023 | 26.07% |
| Q4 2022 | -14.84% |
| Q3 2022 | -15.55% |
| Q2 2022 | 137.82% |
| Q1 2022 | 14495.00% |
| Q4 2021 | -91.09% |
| Q3 2021 | 1081.58% |
| Q2 2021 | -22.45% |
| Q1 2021 | -77.63% |
| Q4 2020 | -78.32% |
| Q3 2020 | 80.68% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 9.97% |
| Q3 2017 | -10.63% |
| Q2 2017 | -1.69% |
| Q1 2017 | 2.61% |
| Q4 2016 | 20.63% |
| Q3 2016 | -22.70% |
| Q2 2016 | -5.61% |
| Q1 2016 | -45.71% |
| Q4 2015 | 31.99% |